Cytokinetics pharmaceuticals news
WebApr 13, 2024 · In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the company’s stock in a transaction on Tuesday, March 28th. The stock was sold at an average price of $35.05, for a total transaction of $438,125.00. ... China Universal Asset Management Co. Ltd. Reduces Position in Madrigal Pharmaceuticals, Inc. Web2 days ago · Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that members of ...
Cytokinetics pharmaceuticals news
Did you know?
Web12 hours ago · Cytokinetics (CYTK) In a report released yesterday, Madhu Kumar from Goldman Sachs maintained a Buy rating on Cytokinetics. The company’s shares closed last Thursday at $35.93, close to its 52 ... WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 …
WebNov 3, 2024 · Cytokinetics , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $2.52 million for the quarter ended September 2024, … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential...
WebApr 10, 2024 · Kumar covers the Healthcare sector, focusing on stocks such as Cytokinetics, Syndax Pharmaceuticals, and Fulcrum Therapeutics. According to TipRanks , Kumar has an average return of 17.8% and a 49 ... WebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as …
WebFeb 27, 2024 · Reata Pharmaceuticals is expecting a Feb. 28 decision for its Friedreich's ataxia hopeful, omaveloxolone. The drug activates Nrf2, a transcription factor that helps …
WebJan 7, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise … how can you ask someone outWebJan 13, 2024 · SOUTH SAN FRANCISCO, Calif., Jan. 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced that the first patient has been dosed in Cohort 2 of REDWOOD-HCM ( R andomized E ... how many people play plants vs zombies bfnWebJul 19, 2024 · Shares in Cytokinetics surged after it reported positive mid-stage results for CK-274, a drug for hypertrophic cardiomyopathy (HCM) that could tread on the toes of Bristol-Myers Squibb's... how many people play piggyWebMar 31, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential … how many people play pk xdWebOct 10, 2024 · While Cytokinetics is pushing forward in ALS, the company’s also developing a drug for heart failure called omecamtiv mecarbil that’s under FDA review. A panel of FDA advisers is set to meet to discuss the drug in mid-December, after which the agency is expected to deliver a decision by February 2024. Filed Under: Clinical Trials how many people play pixelmonWebAug 2, 2024 · About Cytokinetics. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and ... how many people play plants vs zombies gwWebNov 30, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. how many people play plants vs zombies 1